Founding Member Harvey Lodish has been twice honored by the international science community for his path-breaking scientific accomplishments and intellectual leadership.
By learning from nature without overtaxing it, Whitehead Institute Member Jing-Ke Weng aims to help develop potent new drugs for a plethora of medical problems while addressing some of the environmental concerns of typical drug development.
Xin Tang is a postdoc in Whitehead Institute Member Rudolf Jaenisch’s lab investigating brain disease and developing approaches to discover new therapies. We sat down with Tang to learn more about him and his experiences in and out of the lab.
Researchers in Richard Young’s lab at Whitehead Institute and collaborators have discovered how certain cancer therapeutics concentrate within cells -- a finding that could change the way scientists think about drug design.
